3,4-dihydroxyphenylacetaldehyde has been researched along with ANS (Autonomic Nervous System) Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goldstein, DS | 1 |
| Cui, CP; Feng, Y; Gao, S; He, C; Li, BY; Li, KX; Qiao, GF; Sun, J; Sun, X; Wang, HD; Wang, X; Xiong, X; Yan, QX; Yin, RX; Zha, RR | 1 |
1 review(s) available for 3,4-dihydroxyphenylacetaldehyde and ANS (Autonomic Nervous System) Diseases
| Article | Year |
|---|---|
The "Sick-but-not-Dead" Phenomenon Applied to Catecholamine Deficiency in Neurodegenerative Diseases.
Topics: 3,4-Dihydroxyphenylacetic Acid; Autonomic Nervous System Diseases; Dopamine; Humans; Lewy Body Disease; Norepinephrine; Parkinson Disease; Sympathetic Nervous System | 2020 |
1 other study(ies) available for 3,4-dihydroxyphenylacetaldehyde and ANS (Autonomic Nervous System) Diseases
| Article | Year |
|---|---|
Parkinson-like early autonomic dysfunction induced by vagal application of DOPAL in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; alpha-Synuclein; Animals; Autonomic Nervous System Diseases; Baroreflex; Blood Pressure; Electrocardiography; Hypotension, Orthostatic; Male; Mitochondria, Heart; Myocardium; Myocytes, Cardiac; Nodose Ganglion; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Vagus Nerve | 2021 |